PRESS RELEASE published on 03/12/2024 at 17:17, 2 years 1 month ago Results of the Annual General Meeting 2024 for the financial year 2022/23 of BRAIN Biotech AG BRAIN Biotech AG announces successful outcomes at the Annual General Meeting 2024, including approval of silent partnership with Hessen. CEO and Chairman express optimism for future growth and targets Financial Results Annual General Meeting Growth Targets BRAIN Biotech AG Silent Partnership
BRIEF published on 03/05/2024 at 08:05, 2 years 2 months ago BRAIN Biotech and AMSilk Announce Breakthrough in Protein Engineering for Sustainable Textiles BRAIN Biotech AMSilk Protein Engineering Sustainable Textiles Spider Silk
BRIEF published on 03/05/2024 at 08:05, 2 years 2 months ago BRAIN Biotech et AMSilk annoncent une percée dans l'ingénierie des protéines pour des textiles durables CERVEAU Biotechnologie AMSoie Ingénierie Des Protéines Textiles Durables Soie D'araignée
PRESS RELEASE published on 03/05/2024 at 08:00, 2 years 2 months ago Collaboration between BRAIN Biotech and AMSilk: Protein engineering successfully improves structural proteins for performance materials BRAIN Biotech AG and AMSilk collaborate on protein engineering for performance materials, registering their first patent application. The strategic partnership aims for sustainable bio-based solutions in the textile industry Sustainability BRAIN Biotech AG AMSilk Protein Engineering Performance Materials
BRIEF published on 02/29/2024 at 20:45, 2 years 2 months ago BRAIN Biotech AG Announces EUR 5.0 Million Convertible Bond Placement for Growth Initiatives Non-dilutive Financing Convertible Bond Corporate Strategy BRAIN Biotech AG Financing Growth
BRIEF published on 02/29/2024 at 20:45, 2 years 2 months ago BRAIN Biotech AG annonce un placement d'obligations convertibles de 5,0 millions d'euros pour des initiatives de croissance Stratégie D'entreprise Obligations Convertibles BRAIN Biotech SA Financer La Croissance Financement Non Dilutif
PRESS RELEASE published on 02/29/2024 at 20:40, 2 years 2 months ago BRAIN Biotech AG successfully placed EUR 5.0 million convertible bond for the financing of further growth initiatives BRAIN Biotech AG successfully placed EUR 5.0 million convertible bond for financing of growth initiatives. The bonds have an interest rate of 6.52% p.a. and a maturity date of 5 September 2026 Financing Convertible Bond BRAIN Biotech AG Growth Initiatives EUR 5.0 Million
BRIEF published on 02/29/2024 at 20:11, 2 years 2 months ago BRAIN Biotech AG Announces Issuance of EUR 5 Million Convertible Bond Convertible Bonds Shareholder Rights Financial Strategy BRAIN Biotech AG Corporate Financing
BRIEF published on 02/29/2024 at 20:11, 2 years 2 months ago BRAIN Biotech AG annonce l'émission d'une obligation convertible de 5 millions d'euros Stratégie Financière BRAIN Biotech SA Liens Convertibles Financement D'entreprise Droits Des Actionnaires
PRESS RELEASE published on 02/29/2024 at 20:06, 2 years 2 months ago EQS-Adhoc: BRAIN Biotech AG: Issuance of EUR 5 million convertible bond with exclusion of subscription rights BRAIN Biotech AG issues EUR 5 million convertible bond without subscription rights, to be issued on 5 March 2024. Bonds have 6.52% interest rate and due for repayment in 2026 Convertible Bond BRAIN Biotech AG Subscription Rights Interest Rate Repayment
Published on 05/06/2026 at 18:35, 51 minutes ago CoTec to Form an Early Stage Exploration Joint Venture with U.S. Company Copper Intelligence to Target Processing Historical Copper Tailings Opportunities in the Democratic Republic of Congo
Published on 05/06/2026 at 16:30, 2 hours 56 minutes ago Silver Spruce Resources Inc. Announces Results of Annual and Special Meeting of Shareholders
Published on 05/06/2026 at 15:25, 4 hours 1 minute ago Electrovaya Announces Date for Q2-2026 Financial Results & Conference Call
Published on 05/06/2026 at 15:15, 4 hours 11 minutes ago Karbon-X Reports Increased Engagement as Canadian Facilities Reassess Compliance Exposure Ahead of Carbon Deadlines
Published on 05/06/2026 at 15:12, 4 hours 14 minutes ago Revival Gold Announces Closing of $33 Million Brokered Private Placement
Published on 05/06/2026 at 19:18, 7 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/06/2026 at 18:47, 38 minutes ago Amadeus Fire Group starts the current year on a positive note and confirms the forecast for the financial year 2026
Published on 05/06/2026 at 18:30, 55 minutes ago Avolta shareholders approve all proposals of the Board at the Ordinary General Meeting 2026
Published on 05/06/2026 at 18:00, 1 hour 25 minutes ago BOA Concept Group consolide sa présence au Canada
Published on 05/06/2026 at 17:45, 1 hour 40 minutes ago Broadpeak publie son chiffre d’affaires du premier trimestre 2026.
Published on 05/06/2026 at 18:00, 1 hour 25 minutes ago Mise à disposition des documents relatifs à l'AG du 4 juin 2026
Published on 05/06/2026 at 18:00, 1 hour 25 minutes ago Access to information in respect of the General Shareholders’ Meeting to be held on June 4, 2026
Published on 05/06/2026 at 18:00, 1 hour 26 minutes ago Information concerning the total number of voting rights and shares in the share capital as of April 30, 2026
Published on 05/06/2026 at 18:00, 1 hour 26 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 30 avril 2026
Published on 05/06/2026 at 17:45, 1 hour 41 minutes ago Information concerning the total number of voting rights and shares 2026 04 30